Healthcare provider profile · identity verified

John Monroe, MD

Family Practice · NEW LONDON, CT · NPI 1508863226

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	330	70
Rosuvastatin Calcium	Rosuvastatin Calcium	268	74
Pantoprazole Sodium	Pantoprazole Sodium	244	50
Amlodipine Besylate	Amlodipine Besylate	221	58
Lisinopril	Lisinopril	194	50
Ozempic	Semaglutide	191	26
Albuterol Sulfate Hfa	Albuterol Sulfate	187	66
Gabapentin	Gabapentin	180	44
Levothyroxine Sodium	Levothyroxine Sodium	174	38
Omeprazole	Omeprazole	144	30
Famotidine	Famotidine	131	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	127	14
Metoprolol Succinate	Metoprolol Succinate	122	21
Metformin Hcl	Metformin Hcl	121	29
Metoprolol Tartrate	Metoprolol Tartrate	118	29
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	116	27
Metformin Hcl Er	Metformin Hcl	113	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	110	25
Tamsulosin Hcl	Tamsulosin Hcl	102	19
Clonazepam	Clonazepam	101	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	101	29
Duloxetine Hcl	Duloxetine Hcl	100	20
Fluticasone Propionate	Fluticasone Propionate	100	36
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	97	14
Alprazolam	Alprazolam	93	18
Mirtazapine	Mirtazapine	93	21
Montelukast Sodium	Montelukast Sodium	92	21
Baclofen	Baclofen	91	28
Ibuprofen	Ibuprofen	91	23
Jardiance	Empagliflozin	89	17
Oxycodone Hcl	Oxycodone Hcl	89	13
Eliquis	Apixaban	81	16
Losartan Potassium	Losartan Potassium	81	20
Sertraline Hcl	Sertraline Hcl	80	11
Naproxen	Naproxen	79	25
Quetiapine Fumarate	Quetiapine Fumarate	72	12
Torsemide	Torsemide	72	20
Furosemide	Furosemide	71	15
Hydrochlorothiazide	Hydrochlorothiazide	71	18
Chlorthalidone	Chlorthalidone	68	16
Trazodone Hcl	Trazodone Hcl	67	20
Zolpidem Tartrate	Zolpidem Tartrate	65	13
Lorazepam	Lorazepam	63	15
Glipizide Er	Glipizide	62	19
Prednisone	Prednisone	61	28
Potassium Chloride	Potassium Chloride	58	12
Esomeprazole Magnesium	Esomeprazole Magnesium	56	17
Meloxicam	Meloxicam	56	13
Nystatin	Nystatin	54	14
Tizanidine Hcl	Tizanidine Hcl	54	13
Tramadol Hcl	Tramadol Hcl	54	15
Divalproex Sodium	Divalproex Sodium	52	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	50	14
Azithromycin	Azithromycin	49	40
Januvia	Sitagliptin Phosphate	49	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	49	20
Nifedipine Er	Nifedipine	48	suppressed
Simvastatin	Simvastatin	48	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	13
Ondansetron Odt	Ondansetron	42	19
Escitalopram Oxalate	Escitalopram Oxalate	41	suppressed
Carvedilol	Carvedilol	40	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Pregabalin	Pregabalin	39	14
Spironolactone	Spironolactone	38	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Allopurinol	Allopurinol	36	12
Levetiracetam	Levetiracetam	35	suppressed
Ventolin Hfa	Albuterol Sulfate	35	15
Aripiprazole	Aripiprazole	34	suppressed
Buspirone Hcl	Buspirone Hcl	34	suppressed
Linzess	Linaclotide	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Ammonium Lactate	Ammonium Lactate	32	13
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Glimepiride	Glimepiride	32	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	32	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	12
Brilinta	Ticagrelor	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Ketoconazole	Ketoconazole	29	14
Lidocaine	Lidocaine	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Myrbetriq	Mirabegron	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Trulicity	Dulaglutide	27	suppressed
Atenolol	Atenolol	26	suppressed
Levemir Flexpen	Insulin Detemir	26	suppressed
Belsomra	Suvorexant	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Fluconazole	Fluconazole	25	12
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Diazepam	Diazepam	23	suppressed
Primidone	Primidone	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	20	suppressed
Ramipril	Ramipril	20	suppressed
Cefuroxime	Cefuroxime Axetil	19	15
Acetazolamide	Acetazolamide	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Nystop	Nystatin	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Clonidine	Clonidine	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Vraylar	Cariprazine Hcl	17	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Mupirocin	Mupirocin	16	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Sulindac	Sulindac	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	15	suppressed
Levofloxacin	Levofloxacin	15	14
Nabumetone	Nabumetone	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Roflumilast	Roflumilast	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Xcopri	Cenobamate	14	suppressed
Clobazam	Clobazam	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Topiramate	Topiramate	13	suppressed
Trintellix	Vortioxetine Hydrobromide	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	12	suppressed
Risperidone	Risperidone	12	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	11	11
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Colchicine	Colchicine	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Finasteride	Finasteride	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error